Top compounds associated with response to CPVL


Feature Type Standardized
Nominal ANOVA
mRNA ML312 CTRPv2 pan-cancer AAC -0.00037 1
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.00017 1
mRNA CGP-082996 GDSC1000 pan-cancer AAC -0.00021 1
mRNA AZD-2281 FIMM pan-cancer AAC 0.0006 1
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 5.3e-05 1
mRNA BMS-708163 GDSC1000 pan-cancer AAC 1.9e-05 1
Download CSV